Scientific deep-dive

Fat-to-Muscle Ratio: Surgery Versus Drugs

The lean-to-fat ratio improved in both groups at 6, 12 and 24 months. Everyone loses lean tissue when losing weight — the question is the mix, and both interventions improved it.

By Nora Bissett · Pricing Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
5 min read·1 citations

Arguments about muscle loss almost always use the wrong unit. What matters is not how much lean tissue you lose but the mix — how much lean comes off relative to fat. A cohort study measured exactly that after bariatric surgery and after semaglutide or tirzepatide, and the ratio improved in both groups at every time point.[1]

The numbers

Fat-free mass to fat mass ratio. Higher is a more favorable body composition.
Time pointBariatric surgeryGLP-1 receptor agonists
6 months1.81.4
12 months2.11.5
24 months2.01.5

Both groups lost substantial fat mass and moderate fat-free mass, and both improved the ratio between them. Surgery maintained a higher ratio throughout.[1]

The improving ratio is the finding people miss. Losing lean tissue while losing weight sounds like damage, and in isolation it looks like it. But if fat falls faster than lean, the body you end up with is proportionally more muscular than the one you started with, which is the opposite of wasting. Both interventions did that.

Why the comparison between columns is the weak part

This is a single-center cohort study, not a randomized comparison, and people who have bariatric surgery differ enormously from people prescribed a GLP-1 — in starting weight, in how long they have been trying, in what else has failed, and in the post-operative nutrition and follow-up programs that surgery carries with it.

Surgical patients also receive structured protein and supplementation protocols as standard care, which is precisely the intervention shown to preserve lean mass elsewhere. Some of that column difference may be the aftercare rather than the procedure. We cover the broader comparison, and its own methodological problems, in surgery versus GLP-1 drugs.

That both ratios improved is the robust finding. That one column is higher than the other is the fragile one.

The sex difference runs the other way

One stratified result deserves separating out, because it points opposite to a better-known finding. Men preserved fat-free mass better than women, especially after GLP-1 treatment.[1]

Meanwhile, women lose a larger percentage of body weight on these drugs — 10.9% against 6.8% in a review of 64 trials, covered in who loses more weight. Those are not contradictory. They are two different questions: how much total weight comes off, and what it is made of. Merging them would produce a wrong answer in either direction.

The practical implication falls on the same advice regardless: resistance training and adequate protein, which is the only intervention with randomized support for changing the mix. Our lean mass article has the figures, and protein targets has the numbers.

Frequently Asked Questions

References

  1. 1.Wang Z, Wang L, Zhang X, et al. Body Composition Changes After Bariatric Surgery or Treatment With GLP-1 Receptor Agonists JAMA Network Open. 2026. PMID: 41511769.

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.7

Luvo Health

Moving between compounded and brand without changing seller

8.5

Strut Health

Semaglutide at $99/month, 48% under the register median

9.1

Care Bare Rx

Knowing which pharmacy fills the vial — it names Belmar Pharmacy